{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T10:19:46Z","timestamp":1789121986300,"version":"build-2803163510"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","license":[{"start":{"date-parts":[[2023,3,21]],"date-time":"2023-03-21T00:00:00Z","timestamp":1679356800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,7]]},"abstract":"<jats:sec>\n            <jats:title>Objectives:<\/jats:title>\n            <jats:p>Extracorporeal carbon dioxide removal (ECCO<jats:sub>2<\/jats:sub>R) devices are effective in reducing hypercapnia and mechanical ventilation support but have not been shown to reduce mortality. This may be due to case selection, device performance, familiarity, or the management. The objective of this study is to investigate the effectiveness and safety of a single ECCO<jats:sub>2<\/jats:sub>R device (Hemolung) in patients with acute respiratory failure and identify variables associated with survival that could help case selection in clinical practice as well as future research.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Design:<\/jats:title>\n            <jats:p>Multicenter, multinational, retrospective review.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Setting:<\/jats:title>\n            <jats:p>Data from the Hemolung Registry between April 2013 and June 2021, where 57 ICUs contributed deidentified data.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Patients:<\/jats:title>\n            <jats:p>Patients with acute respiratory failure treated with the Hemolung. The characteristics of patients who survived to ICU discharge were compared with those who died. Multivariable logistical regression analysis was used to identify variables associated with ICU survival.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Interventions:<\/jats:title>\n            <jats:p>None.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Measurements and Main Results:<\/jats:title>\n            <jats:p>Of the 159 patients included, 65 (41%) survived to ICU discharge. The survival was highest in status asthmaticus (86%), followed by acute respiratory distress syndrome (ARDS) (52%) and COVID-19 ARDS (31%). All patients had a significant reduction in Pa<jats:sc>co<\/jats:sc>\n                                 <jats:sub>2<\/jats:sub> and improvement in pH with reduction in mechanical ventilation support. Patients who died were older, had a lower Pa<jats:sc>o<\/jats:sc>\n                                 <jats:sub>2<\/jats:sub>:F<jats:sc>io<\/jats:sc>\n                                 <jats:sub>2<\/jats:sub> (P\/F) and higher use of adjunctive therapies. There was no difference in the complications between patients who survived to those who died. Multivariable regression analysis showed non-COVID-19 ARDS, age less than 65 years, and P\/F at initiation of ECCO<jats:sub>2<\/jats:sub>R to be independently associated with survival to ICU discharge (P\/F 100\u2013200 vs &lt;100: odds ratio, 6.57; 95% CI, 2.03\u201321.33).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>Significant improvement in hypercapnic acidosis along with reduction in ventilation supports was noted within 4 hours of initiating ECCO<jats:sub>2<\/jats:sub>R. Non-COVID-19 ARDS, age, and P\/F at commencement of ECCO<jats:sub>2<\/jats:sub>R were independently associated with survival.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/ccm.0000000000005845","type":"journal-article","created":{"date-parts":[[2023,3,21]],"date-time":"2023-03-21T13:07:06Z","timestamp":1679404026000},"page":"892-902","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":19,"title":["Extracorporeal Carbon Dioxide Removal With the Hemolung in Patients With Acute Respiratory Failure: A Multicenter Retrospective Cohort Study*"],"prefix":"10.1097","volume":"51","author":[{"given":"Ravindranath","family":"Tiruvoipati","sequence":"first","affiliation":[{"name":"Department of Intensive Care Medicine, Peninsula Health, Frankston, VIC, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bindu","family":"Akkanti","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Critical Care, Pulmonary and Sleep, University of Texas McGovern Medical School, Houston, TX."},{"name":"Advanced Cardiopulmonary Therapeutics and Transplantation, University of Texas Health-Houston, Houston, TX."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kha","family":"Dinh","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Critical Care, Pulmonary and Sleep, University of Texas McGovern Medical School, Houston, TX."},{"name":"Advanced Cardiopulmonary Therapeutics and Transplantation, University of Texas Health-Houston, Houston, TX."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Barrett","sequence":"additional","affiliation":[{"name":"Department of Critical Care, Guy\u2019s and St Thomas\u2019 NHS Foundation Trust, London, United Kingdom."},{"name":"Centre for Human & Applied Physiological Sciences (CHAPS), School of Basic & Medical Biosciences, Faculty of Life Sciences & Medicine, King\u2019s College London, London, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"May","sequence":"additional","affiliation":[{"name":"ALung Technologies, Inc., LivaNova, Pittsburgh, PA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy","family":"Kimmel","sequence":"additional","affiliation":[{"name":"ALung Technologies, Inc., LivaNova, Pittsburgh, PA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven A.","family":"Conrad","sequence":"additional","affiliation":[{"name":"Department of Medicine, Louisiana State University Health Sciences Center, Shreveport, LA."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,3,21]]},"reference":[{"key":"R1-20250502","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1056\/NEJM200005043421801","article-title":"Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome.","volume":"342","author":"Brower","year":"2000","journal-title":"N Engl J Med"},{"key":"R2-20250502","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1056\/NEJMsa1410639","article-title":"Driving pressure and survival in the acute respiratory distress syndrome.","volume":"372","author":"Amato","year":"2015","journal-title":"N Engl J Med"},{"key":"R3-20250502","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.chest.2017.11.010","article-title":"Re-examining permissive hypercapnia in ARDS: A narrative review.","volume":"154","author":"Barnes","year":"2018","journal-title":"Chest"},{"key":"R4-20250502","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1007\/s00134-022-06640-1","article-title":"The role of acute hypercapnia on mortality and short-term physiology in patients mechanically ventilated for ARDS: A systematic review and meta-analysis.","volume":"48","author":"Gendreau","year":"2022","journal-title":"Intensive Care Med"},{"key":"R5-20250502","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1007\/s00134-016-4611-1","article-title":"Severe hypercapnia and outcome of mechanically ventilated patients with moderate or severe acute respiratory distress syndrome.","volume":"43","author":"Nin","year":"2017","journal-title":"Intensive Care Med"},{"key":"R6-20250502","doi-asserted-by":"crossref","first-page":"e649","DOI":"10.1097\/CCM.0000000000002332","article-title":"Effects of hypercapnia and hypercapnic acidosis on hospital mortality in mechanically ventilated patients.","volume":"45","author":"Tiruvoipati","year":"2017","journal-title":"Crit Care Med"},{"key":"R7-20250502","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1513\/AnnalsATS.202102-104OC","article-title":"An exploratory analysis of the association between hypercapnia and hospital mortality in critically ill patients with sepsis.","volume":"19","author":"Tiruvoipati","year":"2022","journal-title":"Ann Am Thorac Soc"},{"key":"R8-20250502","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1007\/s00134-012-2787-6","article-title":"Lower tidal volume strategy (approximately 3\u2009ml\/kg) combined with extracorporeal CO2 removal versus \u201cconventional\u201d protective ventilation (6\u2009ml\/kg) in severe ARDS: The prospective randomized Xtravent-study.","volume":"39","author":"Bein","year":"2013","journal-title":"Intensive Care Med"},{"key":"R9-20250502","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1007\/s00134-019-05567-4","article-title":"Feasibility and safety of extracorporeal CO2 removal to enhance protective ventilation in acute respiratory distress syndrome: The SUPERNOVA study.","volume":"45","author":"Combes","year":"2019","journal-title":"Intensive Care Med"},{"key":"R10-20250502","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/s13054-018-2038-5","article-title":"Feasibility and safety of low-flow extracorporeal CO2 removal managed with a renal replacement platform to enhance lung-protective ventilation of patients with mild-to-moderate ARDS.","volume":"22","author":"Schmidt","year":"2018","journal-title":"Crit Care"},{"key":"R11-20250502","first-page":"261","article-title":"Early experience of a new extracorporeal carbon dioxide removal device for acute hypercapnic respiratory failure.","volume":"18","author":"Tiruvoipati","year":"2016","journal-title":"Crit Care Resusc"},{"key":"R12-20250502","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1177\/0267659119896531","article-title":"In vivo carbon dioxide clearance of a low-flow extracorporeal carbon dioxide removal circuit in patients with acute exacerbations of chronic obstructive pulmonary disease.","volume":"35","author":"Barrett","year":"2020","journal-title":"Perfusion"},{"key":"R13-20250502","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1177\/0267659119865115","article-title":"In-vitro performance of a low flow extracorporeal carbon dioxide removal circuit.","volume":"35","author":"Barrett","year":"2020","journal-title":"Perfusion"},{"key":"R14-20250502","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s40560-019-0399-8","article-title":"A 2-year multicenter, observational, prospective, cohort study on extracorporeal CO(2) removal in a large metropolis area.","volume":"7","author":"Augy","year":"2019","journal-title":"J Intensive Care"},{"key":"R15-20250502","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1007\/s00134-016-4452-y","article-title":"The feasibility and safety of extracorporeal carbon dioxide removal to avoid intubation in patients with COPD unresponsive to noninvasive ventilation for acute hypercapnic respiratory failure (ECLAIR study): Multicentre case-control study.","volume":"42","author":"Braune","year":"2016","journal-title":"Intensive Care Med"},{"key":"R16-20250502","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1378\/chest.12-0228","article-title":"A novel extracorporeal CO(2) removal system: Results of a pilot study of hypercapnic respiratory failure in patients with COPD.","volume":"143","author":"Burki","year":"2013","journal-title":"Chest"},{"key":"R17-20250502","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s40635-020-00301-7","article-title":"In vitro characterization of PrismaLung+: A novel ECCO2R device.","volume":"8","author":"Hospach","year":"2020","journal-title":"Intensive Care Med Exp"},{"key":"R18-20250502","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1001\/jama.2021.13374","article-title":"Effect of lower tidal volume ventilation facilitated by extracorporeal carbon dioxide removal vs standard care ventilation on 90-day mortality in patients with acute hypoxemic respiratory failure: The REST randomized clinical trial.","volume":"326","author":"McNamee","year":"2021","journal-title":"JAMA"},{"key":"R19-20250502","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s13613-022-01006-8","article-title":"A randomised controlled trial of non-invasive ventilation compared with extracorporeal carbon dioxide removal for acute hypercapnic exacerbations of chronic obstructive pulmonary disease.","volume":"12","author":"Barrett","year":"2022","journal-title":"Ann Intensive Care"},{"key":"R20-20250502","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s40560-018-0304-x","article-title":"Daily use of extracorporeal CO2 removal in a critical care unit: Indications and results.","volume":"6","author":"Winiszewski","year":"2018","journal-title":"J Intens Care"},{"key":"R21-20250502","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1164\/ajrccm.149.2.8306022","article-title":"Randomized clinical trial of pressure-controlled inverse ratio ventilation and extracorporeal CO2 removal for adult respiratory distress syndrome.","volume":"149","author":"Morris","year":"1994","journal-title":"Am J Respir Crit Care Med"},{"key":"R22-20250502","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1136\/thoraxjnl-2019-213591","article-title":"Efficacy and safety of lower versus higher CO(2) extraction devices to allow ultraprotective ventilation: Secondary analysis of the SUPERNOVA study.","volume":"74","author":"Combes","year":"2019","journal-title":"Thorax"},{"key":"R23-20250502","doi-asserted-by":"crossref","first-page":"e0372","DOI":"10.1097\/CCE.0000000000000372","article-title":"Physiologic improvement in respiratory acidosis using extracorporeal Co(2) removal with Hemolung respiratory assist system in the management of severe respiratory failure from coronavirus disease 2019.","volume":"3","author":"Akkanti","year":"2021","journal-title":"Critic Care Explorat"},{"key":"R24-20250502","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1186\/cc13875","article-title":"Extracorporeal carbon dioxide removal for patients with acute respiratory failure secondary to the acute respiratory distress syndrome: A systematic review.","volume":"18","author":"Fitzgerald","year":"2014","journal-title":"Crit Care"},{"key":"R25-20250502","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S2213-2600(20)30079-5","article-title":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: A single-centered, retrospective, observational study.","volume":"8","author":"Yang","year":"2020","journal-title":"Lancet Respirat Med"},{"key":"R26-20250502","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1001\/jama.2020.4031","article-title":"Critical care utilization for the COVID-19 outbreak in Lombardy, Italy: Early experience and forecast during an emergency response.","volume":"323","author":"Grasselli","year":"2020","journal-title":"JAMA"},{"key":"R27-20250502","doi-asserted-by":"crossref","first-page":"23","DOI":"10.5694\/mja2.50883","article-title":"Outcomes for patients with COVID-19 admitted to Australian intensive care units during the first four months of the pandemic.","volume":"214","author":"Burrell","year":"2021","journal-title":"Med J Aust"},{"key":"R28-20250502","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1186\/s13256-019-2051-6","article-title":"Regional anticoagulation with heparin of an extracorporeal CO(2) removal circuit: A case report.","volume":"13","author":"Tramarin","year":"2019","journal-title":"J Med Case Rep"},{"key":"R29-20250502","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1016\/S0140-6736(09)61069-2","article-title":"Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): A multicentre randomised controlled trial.","volume":"374","author":"Peek","year":"2009","journal-title":"Lancet (London, England)"},{"key":"R30-20250502","doi-asserted-by":"crossref","first-page":"e068723","DOI":"10.1136\/bmj-2021-068723","article-title":"Venovenous extracorporeal membrane oxygenation in patients with acute COVID-19 associated respiratory failure: Comparative effectiveness study.","volume":"377","author":"Urner","year":"2022","journal-title":"BMJ"}],"container-title":["Critical Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CCM.0000000000005845","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T17:08:49Z","timestamp":1746205729000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/CCM.0000000000005845"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,21]]},"references-count":30,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/ccm.0000000000005845","relation":{},"ISSN":["0090-3493"],"issn-type":[{"value":"0090-3493","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3,21]]}}}